A Phase 1/2 Study to Evaluate the Safety and Efficacy of Patritumab Deruxtecan in Gastrointestinal Cancers

A Phase 1/2 Study to Evaluate the Safety and Efficacy of Patritumab Deruxtecan in Gastrointestinal Cancers

Disease Types: Colon, Hepatic

Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville

A Phase 1/2 Study to Evaluate the Safety and Efficacy of Patritumab Deruxtecan in Gastrointestinal Cancers

For More Information:

https://clinicaltrials.gov/study/NCT06596694?term=A%20Phase%201%2F2%20Study%20to%20Evaluate%20the%20Safety%20and%20Efficacy%20of%20Patritumab%20Deruxtecan%20in%20Gastrointestinal%20Cancers&rank=1